Results 71 to 80 of about 109,296 (278)

Targeted microwave ablation of localised prostate cancer (VIOLETTE trial): a prospective multicentre study

open access: yesBJU International, EarlyView.
Objective To assess the oncological outcomes of targeted microwave ablation (TMA) using organ‐based tracking (OBT) Fusion® via KOELIS Trinity® (KOELIS, Meylan, France) in men with intermediate‐risk prostate cancer (PCa): the VIOLETTE trial (ClinicalTrials.gov identifier: NCT04582656) Patients and Method In this prospective phase II, multicentre ...
Nicolas Barry Delongchamps   +11 more
wiley   +1 more source

High-risk Locally Advanced Prostate Cancer: Multimodal Treatment Is the Key

open access: yesEuropean Urology Open Science, 2022
Mario Terlizzi, Alberto Bossi
doaj   +1 more source

Heterogeneity of monosomy 3 in fine needle aspiration biopsy of choroidal melanoma. [PDF]

open access: yes, 2013
PurposeTo report on the heterogeneity of monosomy 3 in a fine needle aspiration biopsy obtained transsclerally from choroidal melanoma for prognosis.MethodsAll clinical records for patients who had been diagnosed with choroidal melanoma and underwent ...
Burgess, Barry L   +4 more
core   +2 more sources

Same‐day fluorescence confocal microscopy of MRI‐targeted prostate biopsies: A feasibility study

open access: yesBJU International, EarlyView.
Objectives To determine the diagnostic performance of ex vivo fluorescence confocal microscopy (FCM) for prostate cancer detection in magnetic resonance imaging (MRI)‐targeted biopsy specimens using final histopathology as the reference standard, and to quantify workflow component times relevant to same‐day implementation.
Salim K. Younis   +13 more
wiley   +1 more source

Cervical Small Cell Neuroendocrine Carcinoma Initially Detected on Cytology: Diagnostic Pitfalls and Clues

open access: yesCytopathology, EarlyView.
This case describes the initial detection of cervical small cell neuroendocrine carcinoma on conventional endometrial and cervicovaginal liquid‐based cytology. Given its rarity and high aggressiveness, early recognition and rapid, intensive treatment are crucial for improving patient outcomes.
Yesul Jeong
wiley   +1 more source

Brachytherapy in breast cancer: an effective alternative

open access: yesMenopause Review, 2014
Breast conserving surgery (BCS) with following external beam radiation therapy (EBRT) of the conserved breast has become widely accepted in the last decades for the treatment of early invasive breast cancer. The standard technique of EBRT after BCS is to
Janusz Skowronek, Adam Chicheł
doaj   +1 more source

New developments in the experimental data for charged particle production of medical radioisotopes [PDF]

open access: yes, 2015
The goal of the present work is to give a review of developments achieved experimentally in the field of nuclear data for medically important radioisotopes in the last three years.
Ditrói, F.   +3 more
core   +2 more sources

Non‐Pharmacological Interventions for Cough in Patients With Lung Cancer: A Systematic Review and Meta‐Analysis

open access: yesJournal of Clinical Nursing, EarlyView.
ABSTRACT Background Cough, a prevalent and debilitating symptom of lung cancer, remains poorly managed. Accumulating evidence on non‐pharmacological interventions for lung cancer cough necessitates systematic evaluation to assess their efficacy. Aim To synthesise evidence on non‐pharmacological interventions for managing cough in lung cancer patients ...
Mengyao Cao   +4 more
wiley   +1 more source

Experiences of two different modalities in the management of choroidal melanoma in the Asian Indian population

open access: yesSouth Asian Journal of Cancer, 2017
Background: Choroidal malignant melanoma is a rare intraocular cancer in Asian Indian population. There is a paucity of data from our population comparing iodine 125 (I-125) brachytherapy and enucleation.
Prajna Meeralakshmi   +2 more
doaj   +1 more source

Focal Spot, Spring 2003 [PDF]

open access: yes, 2003
https://digitalcommons.wustl.edu/focal_spot_archives/1093/thumbnail ...

core   +1 more source

Home - About - Disclaimer - Privacy